MedTrace Logo

Metabiomics Colon Cancer Clinical Research Study

NCT02151123 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-09-26

No results posted yet for this study

Summary

The specific aim of the study is to determine the false negative rate of the Metabiomics Colon Polyp and Colorectal Cancer Assay for Cancer.

Conditions

  • Colonic Neoplasms

Sponsors & Collaborators

  • Metabiomics Corp

    lead INDUSTRY

Principal Investigators

  • Jon Vogel, MD · University of Colorado School of Medicine Anschutz Medical Campus

  • Christopher Lieu, MD · University of Colorado School of Medicine Anschutz Medical Campus

  • Patrick Gillevet, PhD · George Mason University

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2020-03-31
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02151123 on ClinicalTrials.gov